Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium vs Ketamine for Post-Hysteroscopy Pain
NCT06745388Phase 4Recruiting
- Sponsor
- Corewell Health
- Start
- Jul 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain and dysmenorrhea comparing Magnesium, IV, Ketamine, IV and Placebo (3 arms). Primary endpoints: Cramping Pain Following Hysteroscopy at 24 hours and Overall Pain following hysteroscopy at 24 hours. Started Jul 2025; status: recruiting.
02
Drugs
magnesium sulfateketamine
03
Conditions
postoperative paindysmenorrhea
Beyond the preview
Go deeper on NCT06745388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06745388.